Key terms
About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LLY news
Yesterday
7:40am ET
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Cardinal Health (CAH)
Jun 12
2:20pm ET
FDA grants traditional approval to Lilly’s Retevmo for thyroid cancer
Jun 12
1:04pm ET
Blue Cross Blue Shield of Michigan to drop weight loss drugs, Bloomberg says
Jun 12
2:26am ET
Eli Lilly: Strong Buy on Diverse Portfolio and Promising Alzheimer’s Pipeline Despite Donanemab’s Challenges
Jun 11
7:33am ET
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Dianthus Therapeutics (DNTH) and Eli Lilly & Co (LLY)
Jun 11
7:13am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Jun 11
6:56am ET
FDA AdCom on Eli Lilly’s donanemab better than anticipated, says Cantor
Jun 11
4:47am ET
Eli Lilly Stock (LLY) Gained on FDA Panel Approval
Jun 10
3:54pm ET
FDA panel votes 11-0 Eli Lilly Alzheimer’s drug benefits outweigh risks
Jun 10
3:15pm ET
FDA panel votes 11-0 Eli Lilly drug efficacious in Alzheimer’s, Bloomberg says
Jun 10
9:26am ET
Bank of America Securities Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Jun 10
6:45am ET
Eli Lilly & Co (LLY) Gets a Buy from Barclays
Jun 09
6:52am ET
Eli Lilly announces detailed results from Phase 2 SYNERGY-NASH trial
Jun 08
5:23pm ET
KO, GOOGL, or TSLA: Which Mega-Cap Stock is the Best Pick?
Jun 07
3:29pm ET
FDA Peripheral & Central Nervous System Drigs Committee Meeting
Jun 07
9:55am ET
Early notable gainers among liquid option names on June 7th
Jun 07
9:28am ET
Structure Therapeutics price target raised to $100 from $83 at BMO Capital
Jun 07
8:10am ET
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Qiagen (QGEN) and Eli Lilly & Co (LLY)
Jun 07
8:02am ET
Eli Lilly price target raised to $957 from $925 at Jefferies
Jun 06
10:42am ET
FDA releases documents ahead of panel review of Eli Lilly’s donanemab
Jun 06
9:25am ET
Jefferies doesn’t think GLP-1s will eliminate Madrigal opportunity in NASH
Jun 06
9:17am ET
Alphabet investors will ‘look positively’ on CFO appointment, says Jefferies
Jun 05
9:20am ET
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), LENSAR (LNSR)
Jun 05
8:28am ET
Madrigal, 89bio, Akero slip after Eli Lilly MASH data released
Jun 05
8:03am ET
Eli Lilly CFO Anat Ashkenazi Resigns, Search for Successor Begins
Jun 05
8:02am ET
Alphabet names Anat Ashkenazi as new CFO
Jun 05
7:46am ET
Eli Lilly announces resignation of CFO Anat Ashkenazi
Jun 04
5:18pm ET
Eli Lilly’s (NYSE:LLY) Tirzepatide Gets UK Endorsement for Obesity
Jun 04
7:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Eledon Pharmaceuticals (ELDN), BioNTech SE (BNTX) and Eli Lilly & Co (LLY)
Jun 03
7:29am ET
Eli Lilly: A Strong Buy on Oncology Overhaul and Expanding Pipeline
Jun 03
4:41am ET
Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Eli Lilly & Co (LLY) and Envista Holdings (NVST)
No recent press releases are available for LLY
LLY Financials
Key terms
Ad Feedback
LLY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LLY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
